The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency — making important discoveries that improve health and save lives.
The grant program seeks to support clinical research that is exploratory and developmental in nature, focusing on understanding the neurobiological mechanisms underlying Substance Use Disorders (SUD) and fundamental brain function relevant to substance use. This program uses the R61/R33 Phased Innovation Award activity code and is designed for exploratory/developmental projects that require budgets exceeding those allowed for the R21 mechanism. The program emphasizes Neuroscience Research on Drug Abuse, including studies that may include clinical trials.